This week, the CDC launched a suite of new opioid prescribing guideline resources for providers, including a mobile app and video series. This is a follow-up to their CDC Guideline for Prescribing Opioids for Chronic Pain, launched last spring, to encourage safer and more effective pain management. 

According to the CDC, “The new Opioid Guide App makes it easier to apply the recommendations in the CDC Guideline for Prescribing Opioids for Chronic Pain into clinical practice by putting the entire guideline, tools and resources in the palm of your hand.” 

The free mobile app, available for Apple and Android devices, features:

  • A Morphine Milligram Equivalent (MME) Calculator
  • Prescribing Guidance
  • Motivational Interviewing (MI) feature to practice effective communication skills

In addition to the app, CDC has developed a video series to help improve understanding about prescription opioids to encourage communication between clinicians and patients. An example of the videos, Even When Prescribed by a Doctor, raises general awareness about opioids and can be shared on social media or used in training sessions or presentations. 

The data suggests there is more work to do, and we stand with our partners and stakeholders to deliver impact. For more information on how the AHA is addressing the opioid abuse crisis, visit: aha.org/behavioralhealth/opioids. To access CDC’s tools and resources, visit: cdc.gov/drugoverdose/prescribing/resources.html.  

Headline
March 8-14 marks Patient Safety Awareness Week. The AHA has several resources including podcasts, videos and reports that show how AHA members are advancing…
Headline
The U.S. District Court for the Southern District of Florida March 6 ruled in favor of five Florida hospitals in a case challenging the methodology used by the…
Chairperson's File
Public
This week, March 8-14, is Patient Safety Awareness Week. Delivering safe, quality care to all patients is the top priority for everyone working in hospitals…
Headline
The Food and Drug Administration March 5 issued a request for information seeking public comments on potential new standards for in-home opioid disposal…
Headline
The Food and Drug Administration has identified a Class I recall of certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus…
Headline
Thomas McGinn, M.D., senior executive vice president and chief physician executive officer at CommonSpirit Health, shares how the organization aligns…